Literature DB >> 11090869

Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement?

E Househam1, M Swash.   

Abstract

The average time taken from symptom onset to diagnosis in motor neuron disease is many months and has shown no sign of improving despite the introduction of riluzole therapy. We performed a retrospective analysis of the time to diagnosis in 57 patients using a structured interview with the patients and/or their carers. In this cohort, studied in England and Wales, the mean time from onset to diagnosis was 16.2 months. An initial incorrect diagnosis, refusal to consider the diagnosis when it was suggested by the informed patient, failure to consider a neurological cause for the patient's symptoms, and failure to make early referral to a neurologist were the major factors leading to delayed diagnosis. Bulbar symptoms were more likely to lead to correct diagnosis than limb-onset features. Ten of our patients made the diagnosis by consulting reference books or the Internet before they were informed of it by their physician.

Entities:  

Mesh:

Year:  2000        PMID: 11090869     DOI: 10.1016/s0022-510x(00)00418-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS).

Authors:  Sabrina Paganoni; Eric A Macklin; Alexandra Lee; Alyssa Murphy; Judith Chang; Amanda Zipf; Merit Cudkowicz; Nazem Atassi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-07-01       Impact factor: 4.092

2.  Pain in amyotrophic lateral sclerosis: a narrative review.

Authors:  Soyoung Kwak
Journal:  J Yeungnam Med Sci       Date:  2022-06-08

Review 3.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

4.  Carcinoma of the tongue and bulbar-onset amyotrophic lateral sclerosis: unusual differential diagnosis.

Authors:  P Volanti; M Mannino; T Piccoli; V La Bella
Journal:  Neurol Sci       Date:  2007-06-30       Impact factor: 3.307

5.  Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis.

Authors:  Bradley R Foerster; Ruth C Carlos; Ben A Dwamena; Brian C Callaghan; Myria Petrou; Richard A E Edden; Mona A Mohamed; Robert C Welsh; Peter B Barker; Eva L Feldman; Martin G Pomper
Journal:  Ann Clin Transl Neurol       Date:  2014-01-13       Impact factor: 4.511

6.  Cortical progression patterns in individual ALS patients across multiple timepoints: a mosaic-based approach for clinical use.

Authors:  Marlene Tahedl; Rangariroyashe H Chipika; Jasmin Lope; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

7.  Modeling delay to diagnosis for amyotrophic lateral sclerosis: under reporting and incidence estimates.

Authors:  Irene Rocchetti; Domenica Taruscio; Daniela Pierannunzio
Journal:  BMC Neurol       Date:  2012-12-23       Impact factor: 2.474

8.  Timeliness of diagnosis in motor neurone disease: a population-based study.

Authors:  Colette Donaghy; Alison Dick; Orla Hardiman; Victor Patterson
Journal:  Ulster Med J       Date:  2008-01

9.  Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia.

Authors:  Hatice Uenal; Angela Rosenbohm; Johannes Kufeldt; Patrick Weydt; Katharina Goder; Albert Ludolph; Dietrich Rothenbacher; Gabriele Nagel
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study.

Authors:  M Galvin; C Madden; S Maguire; M Heverin; A Vajda; A Staines; O Hardiman
Journal:  BMC Health Serv Res       Date:  2015-12-23       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.